Edition:
United States

TiVo Corp (TIVO.O)

TIVO.O on Nasdaq

16.40USD
26 May 2017
Change (% chg)

$0.10 (+0.61%)
Prev Close
$16.30
Open
$16.40
Day's High
$16.70
Day's Low
$16.25
Volume
625,860
Avg. Vol
755,940
52-wk High
$23.40
52-wk Low
$15.06

Select another date:

Wed, May 24 2017

BRIEF-TiVo president and CEO to retire

* Board's corporate governance and nominating committee leading search for new chief executive officer

BRIEF-Tivo - Frontier signed multi-year product license agreement with TiVo

* frontier signed multi-year product license agreement and renewal of its entertainment discovery intellectual property license agreement

BRIEF-TiVo signs multi-year IP license deal with Roku

* Tivo signs multi-year intellectual property license deal with Roku

BRIEF-Tivo settles appraisal litigation related to an acquisition

* Tivo -on March 27, co, Tivo solutions, Fir Tree Value Master Fund, Fir Tree Capital Opportunity Master Fund and The Driehaus Entities executed settlement agreement

BRIEF-Tivo partners with Sky to launch voice search

* Tivo partners with Sky to launch voice search Source text for Eikon: Further company coverage:

BRIEF-TiVo CEO Thomas Carson's FY 2016 total compensation $5.9 mln vs $7.6 mln

* CEO Thomas Carson's FY 2016 total compensation $5.9 million versus $7.6 million - SEC filing Source text for Eikon: (http://bit.ly/2mpkykV) Further company coverage:

BRIEF-TiVo posts Q4 earnings per share $0.08

* TiVo Corporation reports fourth quarter and 2016 full year financial results

BRIEF-TiVo and its units enters into refinancing amendment with lenders party

* On January 26, 2017, co and 2 of its units and certain of co's other units entered into refinancing amendment with lenders party, Morgan Stanley senior funding

BRIEF-Orexigen Therapeutics announces spanish launch of Mysimba

* Orexigen Therapeutics announces spanish launch of Mysimba (naltrexone hcl / bupropion hcl prolonged release) in partnership with laboratorios Farmaceuticos Rovi, S.A.

Judge bars TiVo's claim for trade secret damages from Kantar

A federal judge blocked TiVo Research and Analytics on Wednesday from seeking up to $196 million in damages for trade-secret misappropriation and other torts as part of its patent litigation with a rival market-research firm.

Select another date:

More From Around the Web